Nurix Therapeutics (NRIX) Return on Capital Employed [ROCE] (2020 - 2026)
Nurix Therapeutics (NRIX) reported Return on Capital Employed [ROCE] of 39.43% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 95.72 percentage points from -56.30% a year earlier and up 109.72 percentage points from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Return on Capital Employed [ROCE] of -48.23%, up 2.90 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of -11.24 percentage points (FY2020 to FY2025).
- By fiscal year, Return on Capital Employed [ROCE] came in at -51.13% in FY2024 (+0.69 pp), -51.82% in FY2023 (-2.94 pp), -48.89% in FY2022 (-17.05 pp) and -31.84% in FY2021 (+5.16 pp).
- The fiscal Q3 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q4 2020.
- Year over year, Return on Capital Employed [ROCE] gained in four of the last eight quarters, with an average year-over-year change of +10.68 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q3 2026 (a gain of 95.72 percentage points); the low point was fiscal Q2 2026 (a drop of 26.62 percentage points).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -70.29% (Q2 2026), -55.32% (Q1 2026) and -55.06% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 39.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 39.43% |
| May 31, 2026 | -70.29% |
| Feb 28, 2026 | -55.32% |
| Nov 30, 2025 | -55.06% |
| Aug 31, 2025 | -56.30% |
| May 31, 2025 | -43.67% |
| Feb 28, 2025 | -41.77% |
| Nov 30, 2024 | -42.98% |
| Aug 31, 2024 | -45.47% |
| May 31, 2024 | -54.10% |
| Feb 29, 2024 | -63.82% |
| Nov 30, 2023 | -63.31% |
| Aug 31, 2023 | -59.13% |
| May 31, 2023 | -57.31% |
| Feb 28, 2023 | -56.02% |
| Nov 30, 2022 | -50.05% |
| Aug 31, 2022 | -48.18% |
| May 31, 2022 | -45.26% |
| Feb 28, 2022 | -34.79% |
| Nov 30, 2021 | -28.16% |
API Access
Nurix Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();